For the first minute, almost nothing happens; the tingle arrives somewhere between one and three minutes and is the alkalinity of the pouch, not the nicotine; and by ten minutes the nicotine is genuinely in your blood but nowhere near its peak. The one independent measurement puts blood nicotine at 13 ng/ml at ten minutes from a 9 mg pouch, still climbing, peaking at thirty.
Most accounts of a first pouch are written from memory, which is why they all say “it tingles” and stop. There is actually a measured timeline underneath it — release kinetics, plasma curves, a published mechanism for the burn — and once you have seen the numbers the experience becomes a lot less alarming, because you know which sensations mean something and which are just chemistry doing what it does.
Below is the ten minutes, minute by minute, with the source for each claim. Then the mistakes that make it worse, and a table for when something feels wrong.
The first ten minutes, step by step
-
0:00 — in it goes, under the upper lip. ZYN’s own instruction is “Place it between your gum and lip. Position it comfortably so that it stays in place.” Nordic Spirit adds that the shape “allows for a more comfortable fit between the gum and the upper lip (either side)” and that “The pouch works just as well if placed under the lower lip”. There is no wrong side. I have gone into placement in detail in where exactly to put your first pouch.
-
0:00 to about 1:00 — nothing. This is normal and it is the part nobody warns you about. A dry pouch does nothing at all. It has to take up saliva before anything dissolves, and ZYN’s own description of the mechanism is that “The nicotine within the pouches is extracted into the saliva and absorbed primarily through the mucous membranes found in the mouth”. Until there is saliva in the fleece there is no nicotine in solution. If you are thirty seconds in and wondering whether you got a dud, you did not.
-
1:00 to 3:00 — the tingle, and it is not the nicotine strength. This is the sensation every brand euphemises. ZYN: “You might experience a slight tingling sensation. Don’t worry; this is normal and can be part of the ZYN experience” — and in Switzerland the company has given it a name, “a tingling sensation that we at ZYN call ZYNGLE”.
What is actually causing it is alkalinity. Pouches are deliberately made alkaline so that nicotine sits in its free-base form and crosses the lining of your mouth; BfR measured a median pH of 8.8 across 44 products, with “only one product exhibiting an acidic pH”. And the sensory nerves in your mouth respond to that. A 2022 review in Nicotine & Tobacco Research sets out the mechanism: “The sensory nerves in the oral cavity and throat express the so-called transient receptor potential (TRP) channels, which are responsible for mediating the nicotine-evoked irritation, burning and pain sensations”, and crucially “nicotine (20 mM)-induced CGRP release was more pronounced at alkaline pH, allowing for the deprotonated weak base nicotine to freely pass the plasma membrane”. I should be honest that this review is about nicotine replacement products and cigarettes, not pouches — nobody has demonstrated the mechanism in a pouch specifically, so joining the two is my inference, not a finding. Several of its authors disclose industry funding, including one employed by a nicotine company.
The useful consequence: a stronger-tasting burn does not mean a stronger dose. It largely means a higher-pH product.
-
3:00 to 5:00 — your mouth waters, and you may want to spit. VELO says so plainly: “During initial use, your mouth may produce more saliva. While this typically subsides with regular use, it’s better to spit during your first few uses of the VELO pouch if needed.” Spitting early is not failure and it does not waste the pouch; the bulk of the nicotine has not come out yet.
-
By 5:00 — a large share of the nicotine has left the pouch, at least in a laboratory. BfR’s own release testing found that “In four out of 15 samples, more than 70% of the total nicotine content was released in the first 5 minutes”, and that “most of the nicotine is released within the first 20 minutes”.
But the only measurement I can find of release from a product held in actual human mouths disagrees by a wide margin. Li and colleagues, working on moist snuff rather than modern pouches, report cumulative release of “16.5 ± 4.1%… at 5 min, 24.4 ± 4.5%… at 10 min” for one product and “18.8 ± 5.9%… at 5 min, 29.0 ± 7.2%… at 10 min” for another. That is two to four times lower at five minutes than the laboratory figures. It is a different product class and a different method, and I could find nobody who reconciles the two, so I am reporting both rather than averaging them. In-vitro cells are continuously flushed with fresh fluid; a mouth is not.
-
5:00 to 10:00 — the nicotine reaches you. The one pouch study with no tobacco-industry funding — Queen Mary University of London, “funded by internal funds”, no competing interests declared — measured it directly with a 9 mg ZYN pouch: “Nicotine absorption from the pouches was rapid, reaching 13ng/ml in 10 min, and it remained high at 60 min.”
For scale, in the same study a cigarette peaked at 19.5 ng/ml after six minutes. So at ten minutes a mid-strength pouch has delivered roughly two-thirds of a cigarette’s peak and is still rising.
-
10:00 and after — it keeps climbing, and when it peaks depends on you. This is the finding I find most useful and least reported. Across the published studies, the time to peak blood nicotine tracks how long the subjects were told to keep the pouch in, not any property of the pouch. Held for 45 minutes: peak at 30 minutes. Held for 20 minutes: peak at roughly 22 to 26 minutes. Held for 60 minutes: peak at 59 to 66 minutes. The pouch does not have a Tmax; your habit does.
One more wrinkle, from a manufacturer’s own study: the felt effect arrives before the chemical peak. In Imperial Brands’ 2025 study — “funded by Imperial Brands PLC, manufacturers of the oral nicotine products used in this study” — “For all four study products, the maximum reduction in urge to use nicotine compared to baseline (pre-administration) (Emax) was recorded 15 min post-administration”, while blood nicotine peaked later. Satisfaction at a quarter of an hour, chemistry still climbing.
The mistakes that make a first pouch worse than it needs to be
Chewing it. ZYN’s instruction is unambiguous: “ZYN nicotine pouches should not be chewed.” Chewing bursts the fleece and dumps the contents loose in your mouth, which is where the swallowing problem starts.
Leaving it in for the full advertised time on day one. The brands mostly say around thirty minutes — ZYN “around 30 minutes” across its UK, New Zealand and Serbian sites; VELO “up to 30 minutes” and, on one page, “20-30 minutes”. Only Nordic Spirit publishes a beginner carve-out, recommending “you start with keeping it in your mouth for a short period of time (0-15 minutes)” and reserving “up to an hour” for experienced users. I would follow the beginner figure rather than the headline one, and I have argued that out at more length in how long to keep your first pouch in.
Starting in the middle of the range. In the London study the 9 mg pouch — ZYN’s “Strong”, the fourth rung of six — produced a higher peak blood nicotine than a cigarette, and “Three participants who were light smokers experienced nausea and one vomited.” Nine milligrams is not an extreme product and it made light users sick. Which strength to buy is its own question, and I have answered it in choosing your first nicotine pouch strength.
Shuffling it around with your tongue. In the Swedish Match pharmacokinetic study subjects “were instructed not to manipulate the pouch with the tongue or lips” — that is how the measured figures were produced. Moving it spreads the alkaline material over more tissue, which is a good way to turn a tingle into a sore patch without gaining anything.
Reading the burn as the dose. It is the pH. A product at pH 9 will sting more than one at pH 7.4 at identical nicotine content. Platt and colleagues measured a range across seven mint products from “7.43 for Rogue to 8.98 for Velo” — a meaningful spread, in a study funded by the maker of one of them.
Expecting a cigarette’s hit. You will not get one, and the independent study’s participants said so: they “perceived pouches as delivering more nicotine, being less pleasant, and delivering less of a ‘throat hit'”. Although, honestly, that finding sits oddly against one participant’s free-text complaint that “the hit at the back of the throat was too strong” — so individual experience varies more than the averages suggest.
Troubleshooting: what it means and what to do
| What you are feeling | What it probably is | What I would do |
|---|---|---|
| Nothing at all, first 60 seconds | The pouch has not taken up saliva yet | Wait. Do not chew it to speed it up. |
| Nothing at all after 10 minutes | Genuinely low-delivery product, or it has slipped out of contact with the gum | Check placement. Release varies hugely by product — one pouch in a seven-product study gave up only 48% of its nicotine in 20 minutes against 93% for the fastest. |
| Sharp tingle or burn, building over 2–3 minutes | Alkalinity acting on TRP channels in the mucosa; expected | Nothing. It settles. If it does not, a lower-pH product will sting less — though no brand publishes its pH. |
| Mouth watering, wanting to spit | Normal early response; VELO says to spit if needed | Spit. You lose very little. |
| Nausea, cold sweat, dizziness | Too much nicotine too fast. BfR: “Mild symptoms of intoxication include nausea and vomiting”; of reported pouch cases, “Most of the symptoms reported involved nausea/vomiting and cold sweats” | Take it out immediately. In the London study the worst-affected participant “removed the pouch after 3 min” and that was correct. Buy a lower strength next time. |
| Hiccups | A recognised product-related effect — recorded in both the independent and an industry study, and listed as a known side effect of oral nicotine products generally | Harmless but a signal you are at or above your dose. Shorten the session. |
| Headache | The most commonly recorded adverse event in one clinical study of pouches | Remove it, drink water, drop a strength. |
| Numb patch under the lip | Reported verbatim by a participant as “mouth felt numb” | Normal, transient. Move the next pouch to the other side. |
| Dry mouth afterwards | Dry mouth was the only effect judged “possible or probable” product-related in the Swedish Match study | Water. It is not a sign of harm but it is persistent for some people. |
| A white patch where you keep putting it, weeks or months on | Not a first-session issue. A 2024 case series found that in long-term users “all appeared white at the location where the pouches were placed” | See a dentist. Moving placement is my suggestion rather than published advice — what the case literature actually recommends is stopping and getting the lesion examined. Nothing about a first pouch causes this. |
One thing the table cannot tell you: how much of this you will feel at all. BfR’s own user data found that “While the tobacco cigarette rarely caused irritation to the oral mucosa, all nicotine pouch users reported oral mucosa irritation ranging from moderate (0–20 mg nicotine) to severe (30 mg)” — so oral irritation is close to universal — but it also found that scores for “drowsiness, pounding heart, headache, throat irritation, sweating, dizziness, cold hands and feet, nausea and an urge to vomit were under 3 on average”. Most people have an uneventful first pouch. A minority have a bad one, and the minority skews towards those who use the least nicotine the rest of the time.
If you want the underlying chemistry rather than the experience, that is how nicotine pouches actually work, and the whole first-session walkthrough is your first nicotine pouch, step by step.
Sources
- Przulj D, Myers Smith K, McRobbie H, Pesola F, Ananina I, Ladmore D, Hajek P, “Nicotine delivery from and user reactions to nicotine pouches compared to cigarettes”, Psychopharmacology, 12 December 2025, doi 10.1007/s00213-025-06961-1. Funding: “N/A, the study was funded by internal funds”; “The authors declare no competing interests.” Full text
- Bundesinstitut für Risikobewertung, “Health risk assessment of nicotine pouches”, Updated BfR Opinion no. 023/2022, 7 October 2022. Release kinetics, pH and user-reported effects are BfR’s own measurements. PDF
- Arendt-Nielsen L, Carstens E, Proctor G, Boucher Y, Clavé P, Nielsen KA, Nielsen TA, Reeh PW, “The Role of TRP Channels in Nicotinic Provoked Pain and Irritation from the Oral Cavity and Throat”, Nicotine & Tobacco Research 24(12):1849–1860, December 2022, doi 10.1093/ntr/ntac054. Several authors disclose industry funding; one is employed at the Nicotine Science Center, Fertin Pharma. Article
- Platt SP et al., “Dissolution and physical characterization of oral nicotine pouch products”, Scientific Reports, 6 January 2026, doi 10.1038/s41598-025-34556-5. “This research was funded by Altria Client Services LLC, an affiliate of Helix Innovations LLC, the manufacturer of on! nicotine pouches”; all authors were Altria employees at the time of the study. Full text
- Li P, Zhang Q, Sun Y, Xie J, Zong Y, “A novel model mouth system for evaluation of in vitro release of nicotine from moist snuff”, Chemistry Central Journal 7:176, 11 November 2013. “This work was supported by the fund of China National Tobacco Corporation (110200801024).” Full text
- Lunell E, Fagerström K, Hughes J, Pendrill R, “Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff”, Nicotine & Tobacco Research, 2020, doi 10.1093/ntr/ntaa068. “The present study was funded by Swedish Match AB, Stockholm, Sweden.”
- Chapman F et al., “Evaluation of high-nicotine oral products shows potential to reduce tobacco-related harm by offering satisfying alternatives”, Scientific Reports, 3 October 2025. “This study was funded by Imperial Brands PLC, manufacturers of the oral nicotine products used in this study.” Full text
- Chapman F et al., Psychopharmacology, 23 June 2022, doi 10.1007/s00213-022-06178-6 — adverse events including hiccups and headache. Authors employed by Imperial Brands PLC. Full text
- Miluna-Meldere S et al., “Oral mucosal changes caused by nicotine pouches: case series”, Diagnostic Pathology 19:127, 19 September 2024. Full text
- Brand-owner instructions, read 1 October 2026: ZYN UK, how to use (27 August 2025); ZYN Switzerland (22 May 2025); Nordic Spirit (24 November 2020) and Nordic Spirit (2 September 2024); VELO Ireland (12 June 2024); VELO (9 March 2026).
What I could not establish: no measurement exists of saliva flow rate during nicotine pouch use, so the “your mouth waters” step rests on manufacturers’ own statements rather than a figure. No published study gives per-minute plasma nicotine values before ten minutes in prose; the 2, 4, 6 and 8-minute samples were taken but are reported only in tables, which I have not used. The randomised study specifically comparing pouch durations — Azzopardi et al. 2026 in the Journal of Clinical Pharmacology — is behind a publisher block and remains unread. And no source reconciles the gap between laboratory release at five minutes and the single in-mouth measurement. Last verified 1 October 2026.